Radiosurgery and Avastin for Recurrent Malignant Gliomas

Trial Profile

Radiosurgery and Avastin for Recurrent Malignant Gliomas

Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Feb 2012 Actual end date (Feb 2012) added as reported by
    • 21 Feb 2012 Status changed from active, no longer recruiting to completed as reported by
    • 29 Sep 2011 Planned end date changed from 1 Jul 2011 to 1 Jan 2012 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top